title: [Combined litholytic therapy of urate nephrolithiasis].
abstract: The authors present the analysis of therapy of 72 patients under 70 years of age (40 males - 55.6%, 32 females - 44.4%) with urate nephrolithiasis. Recurrent nephrolithiasis occurred in 51 (70.8%) patients, metabolic disturbances were registered in 38 (52.8%) patients. Efficacy of litholytic therapy with blemoren was 58.3%. In the rest cases the concrements were removed by extracorporeal shock-wave lithotripsy (ESWL). The authors believe that in concrements more than 2 cm in size ESWL should be made in the presence of internal stent, while litholytic therapy prior to ESWL improves treatment results even if ineffectiveness of the former.
authors.forename: N K
authors.initials: NK
authors.lastname: Dzheranov
authors.forename: D A
authors.initials: DA
authors.lastname: Beshliev
authors.forename: R I
authors.initials: RI
authors.lastname: Bagirov
mesh_terms: D000328:Adult; D000368:Aged; D002951:Citrates / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008096:Lithotripsy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D053040:Nephrolithiasis / Q000188:drug therapy / Q000628:therapy*; D015607:Stents; D016896:Treatment Outcome; D014527:Uric Acid / Q000032:analysis
chemical_list: D002951:Citrates; D014527:Uric Acid